Abstrait
Dans la famille des Herpesviridae, huit virus sont strictement humains et sont la cause d’infections dont les manifestations cliniques sont différentes, avec des présentations dermatologiques souvent similaires. On distingue trois sous-familles : les alpha-, les bêta- et les gamma-Herpesviridae (tableau 31.1).
Preview
Unable to display preview. Download preview PDF.
Références
Nguyen HO, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450–458.
Vazquez M, La Russa PS, Gershon AA et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001; 344:955–960.
Quirk M. Varicella vaccination reduces risk of herpes zoster. Lancet Infect Dis 2002; 2:454.
Fillet AM, Sadzot-Devaux C, Rentler B. Virus varicelle-zona. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, éd. Virologie médicale. Paris: Estem; 2003. p. 179–193.
Bourgault-Villada I. Réponses immunitaires aux virus: I. Réponse immunitaire cellulaire. In: Chosidow O, ed. Virus et peau. Paris: Esterm; 1994: 17–20.
Straus SE, Ostrove JM, Inchauspe G et al. NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108:221–237.
Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Int Med 1995; 155:1605–1609.
Guess HA, Broughton DD, Melton LJ, Kurland LT. Population-based studies of varicella complications. Pediatrics 1986; 78:723–727.
Nikkels AF, Pierard GB. Necrotizing varicella zoster virus folliculitis. Eur J Dermatol 2003; 13:587–589.
Frangides CY, Pneumatikos I. Varicellazoster virus pneumonia in adults: report of 14 cases and review of the literature. Eur J Intern Med 2004; 15:364–370.
Snoeck R, De Clercq E. Herpesvirus infections in immunocompromised patients. In: Klastersky J, ed. Infectious complications of cancer. Boston: Kluwer Academic Publishers; 1995: 149–71.
Thomson KJ, Hart DP, Banerjee L et al. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogenic haemopoietic stem cell transplantation. Bone Marrow Trans 2005; 35:1065–1069.
Mofenson LM, Oleske J, Serchuck L et al. Treating opportunistic infection among HIV-exposed and infected children: recommendations from CDC, the National Institute of Health, and the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:S1–84.
Kellner B, Kitai L, Krafchik B. What syndrome is this ? Pediatr Dermatol 1996; 13:341–344.
Chidiac C, Bruxelle J, Daurès J et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62–69.
Liesegang TJ. Varicella zoster viral disease. Mayo Clin Proc 1999; 74:983–988.
Furuta Y, Ohtani F, Aizawa H et al. Varicellazoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J 2005; 24:97–101.
Glesby MY, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with HIV. Clin Infect Dis 1995; 21:370–375.
Pope JE, Krizova A, Ouimet JM et al. Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or non-inflammatory musculo-skeletal disorders. J Rheumatol 2004; 31:274–279.
Toney JF. Skin manifestations of herpesvirus infections. Curr Infect Dis Rep 2005; 7:359–364.
Huraux JM. Généralités sur les Herpesviridae. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, eds. Virologie médicale. Paris: Estem; 2003. p. 153–159.
Laurent R. Herpès. Encycl Med Chir (Elsevier SAS, Paris), Dermatologie, 98-290-A-10, 2002. 11 p.
Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357:1513–1518.
Rozenberg F. Physiopathologie de l’infection à virus herpès simplex. Virologie 2000; 4 (n o spécial):7–14.
Snoeck R, De Clercq E. Herpes virus infection in immunocompromised patients. In: Klastersky J, ed. Infections complication of cancer. Amsterdam: Kluwer Academic Publishers; 1995: 149–171.
Martin L. Herpès orofacial, autres localisations herpétiques. Ann Dermatol Venereol 2002; 129:494–506.
Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 2005; 32:84–89.
Malkin JE, Morand P, Malvy D et al. Seroprevalence of HSV1 and HSV2 infections in the general French population. Sex Transm Infect 2002; 78:201–203.
Mertz G, Benedetti JK, Ashley R et al. Risk factors for the sexual transmission of génital herpes. Ann Intern Med 1992; 116:197–202.
Halioua B, Malkin JB. Epidemiology of genital herpes: recent advances. Eur J Dermatol 1999; 9:177–184.
Corey L. The current trend in genital herpes: progress in prevention. Sex Transm Dis 1994; 21(suppl. 1):538–544.
Christenson B, Bottinger M, Swensson A et al. A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls. J Infect Dis 1992; 25:147–154.
Ashley R. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med 1993; 64:174–183.
Pedoby RG, Andrews N, Brown D et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80:185–191.
Lecat M. Herpès cutanéo-muqueux chez l’immunocompétent et grossesse. Ann Dermatol Venereol 2002; 129:523–532.
Janier M, Lassau F, Bloch J et al. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris. Int J STD AIDS 1999; 10:522–526.
Wald A, Zeh J, Secke S et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844–845.
Brown ZA. Genital herpes complicating pregnancy. Dermatol Clin 1998; 16:805–810.
Fonnest G, De La Fuente Fonnest I, Weber T. Neonatal herpes in Denmark: 1977–1991. Acta Obstet Gynecol Scand 1997; 76:355–358.
Berrebi A, Thene M, Nowakowska D. Herpès et grossesse. Rev Prat Gynecol Obstet 2000; 44:25–28.
Huraux JM, Huraux-Rendu C, Blanchier H et al. Herpès génital et grossesse: des mesures essentiellement préventives. Rev Prat 1994; 44:499–503.
Huraux JM. Épidémiologie des infections à herpes simplex virus chez la femme enceinte et l’enfant et transmission materno-fœtale. Presse Med 1995; 24(suppl. 25):2–3.
Berland M. Herpès génital et accouchement. Rev Fr Gynecol Obstet 1991; 86:639–643.
Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing World. Herpes 2004; 11(suppl. 1):14A–35A.
O’_Farrel N, Tovey SJ. High cumulative incidence of genital herpes amongst HIV-1 seropositive heterosexuals in south London. Int J STD AIDS 1994; 5:415–418.
Freedman E, Mindel A. Epidemiology of herpes and HIV co-infection. J HIV Ther 2004; 9:4–8.
Heng MC, Heng SY, Allen SG. Co-infection and synergy of HIV-1 and HSV-1. Lancet 1994; 343:255–258.
Schacker T. The role of HSV in the transmission and progression of HIV. Herpes 2001; 8:46–49.
Suligoi B, Dorrucci M, Volpi A et al. Italian seroconversion study. Absence of an effect of herpes simplex virus type 2 infection on HIV disease progression: data from a cohort of HIV-positive individuals with known date of seroconversion. AIDS 2001; 15:133–135.
Caumes E. Herpès non génital de l’adulte: clinique, valeur diagnostique de la clinique, évolution. Ann Dermatol Venereol 2002; 129:547–602.
Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. Herpes simplex viruses 1 and 2. Dermatol Clin 2002; 20:249–266.
Gill MJ, Arlette J, Buchan KA. Herpes simplex virus infection of the hand. J Am Acad Dermatol 1990; 22:111–116.
Toney JF. Skin manifestations of herpes virus infection. Curr Infect Dis Rep 2005; 7:354–364.
Colin J. Les kératites herpétiques. Infect Immun 1994; 1:158–164.
Bossi P. Herpès génital: épidémiologie, modes de transmission, clinique, excrétion virale asymptomatique, conséquences sur les autres maladies sexuellement transmissibles, traitement et prévention. Ann Dermatol Venereol 2002; 129:477–493.
Janier M. Herpès des organes génitaux externes en dehors de la grossesse. Ann Dermatol Venereol 2002; 129:586–596.
Murakami S, Mizobuchi M, Nakashiro Y et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124:27–30.
Huraux JM, Rosenberg F. Herpes simplex virus. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, éd. Virologie médicale. Paris: Estem; 2003: 161–177.
Devergie A. Chimiothérapie antivirale de l’herpès des greffés de moelle osseuse. Virologie 2000; 4:39–41.
Aurelian L, Koluba H, Burnett JW. Understanding the pathogenesis of HSV-associated erythema multiformis. Dermatology 1998; 197:219–222.
Kimberlin DW. Advances in the treatment of neonatal herpes simplex virus infections. Rev Med Virol 2001; 11:157–163.
Conférence de consensus: prise en charge de l’herpès cutanéo-muqueux chez l’immunocompétent, manifestations oculaires exclues. Ann Dermatol Venereol 2002; 129:667–679.
Wald A, Zeh J, Barnum G et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8–15.
Sacks SL, Griffiths PD, Corey L et al. HSV shedding. Antiviral Res 2004; 63(suppl. 1):S19–26.
Braig S, Luton D, Sibony O et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and virus shedding. Eur J Obstet Gynecol Reprod Biol 2001; 96:55–58.
Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 15:702–703.
Nicolas JC, Meyohas MC. Virus Epstein-Barr. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, ed. Virologie médicale. Paris: Estem; 2003. p. 213–227.
Aractingi S, Fermand JP, Morinet F. Infections à virus d’Epstein-Barr et pathologie cutanée. In: Chosidow O, ed. Virus et peau. Paris: Estem; 1994. p. 105–109.
Toney JF. Skin manifestations of herpes virus infections. Curr Infect Dis Rep 2005; 7:354–364.
Hofmann B, Schuppe HC, Adams O et al. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol 1997; 14:273–277.
Hsiah MY, Huang PH. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infection. Br J Dermatol 2004; 151:201–206.
Taylor S, Drake SM, Dedicoat M, Wood MJ. Genital ulcers associated with acute Epstein-Barr virus infection. Sex Transm Infect 1998; 74:296–297.
Pelletier F, Leblanc L, Estavoyer JM et al. Ulcère de Lipschütz au cours d’une primoinfection à virus Epstein-Barr. Ann Dermatol Venereol 2002; 129:905–907.
Pelletier F, Aubin F, Puzenat E et al. Lipschütz genital ulceration: a rare manifestation of parathyroid fever. Eur J Dermatol 2003; 13:297–298.
Laurent R, Drobacheff C. Manifestations dermatologiques de l’infection VIH et du SIDA. In: Bessis D, Guilhou JJ, éd. La pathologie dermatologique en médecine interne. Paris: Arnette; 1999. p. 533–546.
Itin P, Rufli T, Rüdlinger R et al. Oral hairy leukoplasia in a HIV-negative renal transplant patient. Dermatologica 1988; 177:126–128.
Corso B, Eversole LR, Hutt-Fletchner L. Hairy leukoplasia: EBV receptor on oral keratinocyte plasma membranes. Oral Surg Oral Med Oral Pathol 1989; 67:416–421.
Kano Y, Shidhara T. Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 2000; 22:196–204.
Snoeck R, De Clercq E. Herpes-virus infection in immunocompromised patients. In: Klastersky J, ed. Infectious complications of cancer. Boston: Kluwer Academic Publishers; 1995: 149–171.
Alain S, Mazeron MC. Cytomegalovirus. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, ed. Virologie médicale. Paris: Estem; 2003. p. 195–211.
Britt WJ, Alford CA. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, eds. Virology. 3e éd. Philadelphia: Lippincott-Raven; 1996. p. 2493–2523.
Drago F, Aragone MG, Lugani C, Rebora A. Cytomegalovirus infections in normal and immunocompromised humans. Dermatology 2000; 200:189–195.
Bournerias I, Boisnic S. Cytomegalovirus. In: Chosidow O, ed. Virus et peau. Paris: Estem; 1994. p. 115–121.
Klemola E. Hypersensitivity reaction to ampicillin in cytomegalovirus mononucleosis. Scand J Infect Dis 1970; 2:29.
Nico MMS, Cymbalista NC, Hurtado YCP, Borges LHB. Perianal cytomegalovirus ulcer in an HIV infected patient: case report and review of literature. J Dermatol 2000; 27:99–105.
Weigand DA, Burgdorf WHC, Tarpay MM. Vasculitis in cytomegalovirus infection. Arch Dermatol 1980; 116:1174–1176.
Qazi NA, Morlese JF, Walsh JC et al. Case report: severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART. AIDS Read 2002; 12:452–454; 456–457.
Dauden E, Fernandez-Buezo G, Fraga J et al. Mucocutaneous presence of cytomegalovirus associated with immunodeficiency virus infection: discussion regarding its pathogenic role. Arch Dermatol 2001; 137:443–448.
Seishima M, Oyama Z, Yamamura M. Erythema multiforme associated with cytomegalovirus infection in non-immunosuppressed patients. Dermatology 2001; 203:299–302.
Oskay T, Karademir A, Kutluay L. Vesicular and pustular eruption related to cytomegalovirus in an immunocompetent patient. Clin Exp Dermatol 2003; 28:610–612.
Kuroda K, Yabunami H, Hisanaga Y. Acute hemorrhagic oedema of infancy associatedwith cytomegalovirus infection. Br J Dermatol 2002; 147:1254–1257.
Casals DS, Nunes Ede A, Maruta CW et al. Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. J Dermatol 2003; 30:332–336.
Toome BK, Bowers KE, Scott GA. Diagnosis of cutaneous cytomegalovirus infection: a review and report of a case. J Am Acad Dermatol 1991; 24:857–863.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Laurent, R. (2008). Infections à Herpesviridae. In: Manifestations dermatologiques des maladies infectieuses, métaboliques et toxiques. Springer, Paris. https://doi.org/10.1007/978-2-287-48494-0_10
Download citation
DOI: https://doi.org/10.1007/978-2-287-48494-0_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-48493-3
Online ISBN: 978-2-287-48494-0